Serum transfer of collagen-induced arthritis in mice by unknown
SERUM  TRANSFER  OF COLLAGEN-INDUCED  ARTHRITIS 
IN  MICE* 
BY JOHN  M.  STUART AND FRANK J.  DIXON 
From the Department of Immunology,  Scripps Clinic and Research Foundation 
La Jolla, California  92037 
In  1977, Trentham et al. (1) described a model of polyarthritis induced in rats 
by immunization with type II collagen. The lesions identified on histopathologic 
examination resembled those of human rheumatoid arthritis (RA) 1. In addition, 
the arthritis was associated with high levels of both cellular and humoral immu- 
nity to collagen (2). Since collagen-related autoimmunity has also been described 
in individuals with RA (3-6), Trentham proposed that the same pathophysiologic 
mechanism  responsible for collagen-induced arthritis  in rats  might  cause some 
of the  lesions in  RA (7).  Type II  collagen  is  limited  in  its bodily distribution 
primarily to cartilage (8), so an immune response to this specific collagen could 
account for the predilection of RA to involve diarthroidal joints. However, the 
earliest lesion of collagen-induced arthritis is synovial proliferation in the absence 
of apparent cartilage abnormality. 
To determine the precise sequence of events leading to experimental arthritis, 
detailed investigations of the immune response to type II collagen in rats were 
undertaken.  Kinetic  studies showed rising  levels of both cellular and  humoral 
immunity to collagen at the time arthritis appeared (9).  Apparently, the disease 
could be transferred with either cells (10) or with an immunoglobulin concentrate 
(11) from collagen-immunized donors. 
In addition  to rats,  some mice were susceptible to collagen-induced arthritis 
(12) but, according to one report (13), only strains of the H-2  q major histocom- 
patibility haplotype.  In  humans,  the  major histocompatibility  haplotype  HLA- 
DR4 is also associated with immune responsiveness to collagen (14) and with RA 
(15), providing additional  evidence that  collagen-induced arthritis  is a  relevant 
model  for  the  study  of RA.  Unfortunately,  no  simple  correlation  is  obvious 
between the immune response to collagen and collagen-induced arthritis in mice. 
Although  strains  that  are susceptible to arthritis  have concomitantly high  anti- 
collagen responses, many resistant strains have equally high responses. Either the 
immune response to collagen is qualitatively different in the latter stains, or other 
factors  in  the  host  milieu  are  independent  determinants  of susceptibility  to 
arthritis. 
The present studies were undertaken  to determine if arthritis could be trans- 
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ferred with a  serum concentrate from immunized donor DBA/1  mice to unim- 
munized  recipients,  to identify host  factors important  for disease  susceptibility 
and  to  clarify the  reasons  for  prominent  synovitis in  the  absence  of apparent 
cartilage  damage.  We  found  that  a  concentrate  of immune  sera  could  induce 
arthritis,  that  susceptibility  to  transferred  arthritis  was  independent  from  the 
recipients' H-2 haplotype, that transferred anti-type II collagen antibodies local- 
ized both to the joints and  to other  cartilaginous  tissues,  and that  IgG and  C3 
deposited on the articular surface of cartilage caused synovitis even though  the 
cartilage appeared normal by routine histologic examination. 
Materials and  Methods 
Animals.  DBA/1, B10.D2, C57BL, and BALB/c mice were bred and maintained in 
the mouse colony of the Scripps Clinic and Research Foundation. Both males and females 
were used, all between 8 and 12 wk old at the time of immunization or transfer of serum. 
Wistar/Furth rats (125-150 g) that originated from the Microbiological Associates' colony 
were obtained from Harlan-Sprague-Dawley (Walkersville, MD). All of the animals were 
housed in plastic cages with absorbent bedding. They were fed a standard rodent chow 
diet and water ad libitum. 
Collagen.  Native type II collagen was obtained from chick sternae or bovine articular 
cartilage.  The  methods  of preparation  and  the  criterion  for  purity  were  described 
previously (16). 
Immunization.  Collagen for immunization was dissolved in 0.01 N acetic acid by stirring 
overnight at 4°C at a concentration of 1 mg/ml. Mice were primed by injection at the 
base of the  tail  with  25  gg of chick type II collagen emulsified in  complete Freund's 
adjuvant. Freund's adjuvant was made by pulverizing lyophilized heat-killed mycobacteria 
(strains C, DT, and PN, Ministry of Agriculture, Fisheries, and Food, Weybridge, Surrey, 
England) with a mortar and pestle. The ground mycobacteria were added to incomplete 
Freund's adjuvant at a  concentration  of 2  mg/ml. An emulsion was formed by slowly 
adding an equal volume of collagen solution to the adjuvant and mixing with a blade type 
emulsifier at high speed (Sorval Omnimixer, Dupont Co., Wilmington,  DE).  The mice 
received an intraperitoneal booster injection of 25 gg of collagen without adjuvant 21  d 
after the initial injections. 
Rats were immunized with 50 #g of bovine type II collagen emulsified with incomplete 
Freund's adjuvant injected intradermally into the right hind footpad and were given a 
booster injection of an identical emulsion 7 d  later.  All of the solutions and emulsions 
were maintained at 4°C or in an ice bath to prevent denaturation of the collagen before 
immunization. 
Evaluation of Arthritis.  Mice were observed daily for the presence of arthritis. Severity 
was graded visually by using a  method adapted from that previously described for rats 
(17), and swelling was measured with constant tension calipers (Starrett Co., Athol, MA) 
at the dorsum of the foot, ankle, and wrist. 
Histological Evaluation.  Mice were killed at intervals, and tissues for routine histological 
examination were placed in Bouin's solution for 48 h, decalcified for 2-4 d in decalcifying 
solution (Scientific Products, McGraw Park, IL) and imbedded in paraffin. Finally, sections 
were cut and stained with hematoxylin and eosin. Sections to be studied with immunoflu- 
orescence were prepared by a method to be described elsewhere. ~ Briefly, the limbs were 
decalcified in a solution of 0.05% N-ethylmaleimide and 7% ethylenediaminetetra-acetic 
acid, pH 7.0, to which 55 g of ammonium sulfate per 100 ml was added. After decalcifi- 
cation was complete, the limbs were placed in the same buffer without ammonium sulfate 
for 30 min and then frozen onto a cork support by using Tissuetech O.T.C. compound 
(Miles  Laboratories,  Naperville,  IL).  Sections  were  cut  4  #m  thick  and  stained  with 
2 Stuart, J. M., M. West, J. H. Slack, C. B. Wilson. A simplified method for preparation  of small 
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fluorescein-conjugated goat anti-mouse F(ab')~. This method preserves immunoglobulin 
within the joint for immunofluorescence study after sectioning of the frozen decalcified 
tissues. 
Preparation of Serum Concentrate for Transfer Studies.  Immune sera for transfer were 
obtained from DBA/1  mice 5 wk after primary immunization with collagen• The sera 
were pooled, and an equal volume of saturated solution of ammonium sulfate was added 
to  precipitate  the  immunoglobulin.  The  precipitate  was  collected  by  centrifugation, 
redissolved in a minimal volume of water, and dialyzed against 0.15 M NaCI and 0.01  M 
sodium phosphate (PBS) at pH 7.2. The volume was then adjusted to ½ that of the original 
serum, and the concentrate was sterilized by microporous filtration through a  0.45-~m 
disposable filter unit.  The concentrate was either used immediately or frozen at -80°C 
until needed. 
Serum concentrate from rats was prepared as previously described (11). 
Immunoassay of Antibodies to Collagen.  An enzyme-linked immunoassay system (ELISA) 
was used to quantitate antibody to collagen. This was performed essentially as previously 
described (18) except for minor modifications. Immulon II plates (Dynatech, Alexandria, 
VA)  were  coated  with  collagen at  a  concentration  of  10  ~g/ml  in  0.4  ionic  strength 
phosphate buffer, pH 7.6, by incubation at 4°C overnight. Plates were washed with PBS 
containing 0.05% Tween 20 (PBS-Tween) and incubated with serum-diluted PBS-Tween 
containing 1% bovine serum albumin (BSA) for 4 h at room temperature. After washing 
with PBS-Tween, conjugate diluted  1  : 1,000 in PBS-Tween-BSA was added to each well. 
The conjugates used in these experiments consisted of affinity-purified peroxidase goat 
anti-mouse  IgG (Tago,  Burlingame,  CA)  and  peroxidase  rabbit  anti-rat  IgG (Cappel 
Laboratories, Cochranville, PA). The plates were developed with orthophenylenediamine 
(OPD) as the substrate. 40 mg of OPD was dissolved in 100 ml of citrate-phosphate buffer, 
pH 5.0, to which 40 #1 of 30% H20~ was added immediately before use. The absorbance 
of each  well  was  determined  by  using  a  microELISA reader  (Model  600,  Dynatech 
Laboratories, Alexandria, VA) at a test wavelength of 492 nm and a reference wavelength 
of 595  nm.  Results are  reported as units  of absorbance.  Dilutions  of affinity purified 
anticollagen antibodies and normal sera were included in all runs to provide standard 
reference values. 
Isotopic Labeling of Anticollagen Antibodies.  Anticollagen antibodies were absorbed from 
immune DBA/1  serum onto native chick type II collagen coupled to Sepharose. While 
•  125  still attached to the collagen-Sepharose, they were labeled with  I by using lactoperoxi- 
dase. Chick type II collagen was dissolved in 0.4 ionic strength phosphate buffer, pH 7.6, 
at a concentration of 2 mg/ml by stirring overnight at 4°C. This was coupled to CNBr- 
activated Sepharose 4B as previously described (11).  After washing with PBS,  40/zl of 
collagen-Sepharose was added  to an equal volume of immune serum and incubated at 
4°C overnight. The Sepharose was then washed three times by suspending it in 4 ml of 
PBS, centrifuging at 400 g for 2 min, aspirating the supernatant fluid and repeating the 
procedure. 50 t*l of 0.5 M phosphate buffer, pH 7.2, and 50 #i of Enzymobeads (Bio-Rad 
Laboratories, Burlingame, CA) were then added to the Sepharose.  1 mCi of ~5I in 25 #! 
of 0.1  M NaOH was neutralized with an equal volume of 0.1  M HCI and added to the 
Sepharose suspension. Finally, 20 #1 of 1%/~-I)-glucose was added and the reaction allowed 
to proceed for 20 min at room temperature. The reaction mixture was recovered in  1.4 
ml ofO.2 M glycine-HCl, pH 2.3, and placed on a PD-10 column that had been equilibrated 
with PBS. The reaction vial was washed with an additional  1 ml of glycine-HCl and the 
desorbed,  ~25I-labeled antibody recovered by washing the column with  3 ml of PBS.  A 
total of 250 #Ci of 1251 was incorporated into TCA-precipitable protein. 
Control immunoglobulin from sera of normal DBA/1  mice was labeled in an identical 
fashion except that absorption was accomplished with protein A-Sepharose and ~3~I was 
used to permit differential identification of the labeled preparations. Use of this method 
permitted isolation of isotopicaily labeled anticollagen antibodies and normal immuno- 
globulin that had been subjected to identical conditions of pH and oxidation. 
Unimmunized DBA/1  mice were given approximately equal quantities of isotopically 
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intervals,  these  mice were bled and  killed;  then  the quantities of both  13~I and  125I in 
various tissues were determined. The hind limbs were severed proximal to the ankle, the 
forelimbs proximal to the wrist, and the internal organs individually removed. Each of 
the limbs and internal organs was placed in a  12 mm ×  75 mm glass tube and counted in 
a gamma scintillation counter. After correction for background and channel overlap, the 
quantity of both isotopes in each tissue was determined, and the results were reported as 
the percentage of the isotope detected compared to the total injected or as the ratio of 
~z~I to  ~s'I in  a  given tissue compared to that in  serum.  The latter ratio provided an 
indication of whether either isotope was selectively concentrated compared to its blood 
level. 
Results 
Passive  Transfer  of Arthritis.  Sera  were  obtained  from  the  blood  of  "~200 
DBA/1  mice 5 wk after primary immunization with native chick type II collagen, 
a  time when both arthritis and peak levels of IgG anticollagen antibodies occur. 
All mice were bled whether arthritic (,~60%) or not and the blood was pooled. 
An immunoglobulin concentrate was obtained from these sera, dialyzed against 
PBS, sterilized, and administered to unimmunized  DBA/1  recipients. Although 
concentrate from 3 ml of serum would transfer arthritis occasionally, concentrate 
from 2  ml given on 2  consecutive days reliably transferred arthritis  to  100%  of 
the  recipients  (Table  I).  Recipients  of control  sera from mice immunized  with 
complete Freund's adjuvant and  buffer alone did not  develop arthritis.  Shown 
in  Fig.  1 is the arthritic  hind  limb from a  mouse 48  h  after passive transfer of 
serum.  In previous studies (10,  11),  arthritis induced  in rats by injecting either 
immune  cells  or  serum  was  limited  to  the  hind  limbs.  However,  in  mice,  this 
disease was often evident in or limited to the forelimbs. 
Histopathologically,  the  transferred  arthritis  resembled  early  disease  in  im- 
munized  donors  (Fig.  2).  There  was  synovial  proliferation  with  early  pannus 
formation, subsynovial infiltration of inflammatory cells, exudation of cells into 
the  joint  space,  widening  of  the  space  between  the  cartilage  surfaces  with 
excessive convolution of the synovium, and deposition of a fibrinlike material on 
the surface of the articular cartilage in some areas. 
Time Course of Transferred Arthritis.  In all cases, the  transferred arthritis  was 
TABLE  I 
Passive Transfer of Arthritis in DBA/1 Mice 
Donor immunized with:* 
ml of Concentrate given 
to recipients* 
Day 0  Day 1 
Recipients ar- 
thritic/total 
Unimmunized  0.75  0.75  0/4 
CFA alone  0.75  0.75  0/6 
CII + CFA  0.75  0.75  6/6 
CII + CFA  1.0  None  I/4 
* DBA/1 donors were immunized with complete Freund's adjuvant (CFA) 
either with or without  100 /~g of chick type  II collagen (CII), those 
receiving collagen were given an additional  100 #g of collagen intraper- 
itoneally 21 d later and were bled 4 wk after the primary immunization. 
* Sera from immunized donors were pooled, the immunoglobulin precip- 
itated  with ammonium sulfate and the precipitate  redissolved so that 
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FIGURE  I.  Shown is the hindpaw of a  mouse with passively transferred arthritis (A) 48 h 
after intravenous injection of immunoglobulin concentrate and a  normal  hindpaw (B)  for 
comparison. Note swelling of the ankle with loss of bony landmarks and increased thickness 
of the dorsum from the affected foot. 
transient. Disease was first evident 24-48 h after the second injection of serum 
concentrate and  reached maximal  severity within  the  next  24  h.  During the 
following 4-5  d,  the arthritis gradually resolved (Fig.  3),  and joints examined 
histopathologically 2 wk after transfer were free from inflammation or perma- 
nent damage. Serial bleedings of transfer recipients showed that the exogenous 
anticollagen antibody rapidly left their sera and was undetectable within 2 wk. 
Ident~cation  of lgG in Joints of Mice After Passive Transfer of Serum.  Sections of 
arthritic joints  from  transfer recipients  were  stained  with  fluorescein labeled 
antimouse IgG and  C3,  both  of which subsequently localized to  the articular 
surface of the cartilage (Fig. 4).  No staining was evident in the synovial tissue. 
Staining tended to be most intense at the periphery of the cartilage and decreased 
to  a  thin  line  near  the  center of the  weight-bearing portion  of the joint.  In 
sections from normal joints of unimmunized control mice, the entire articular 
surface was  negative for specific fluorescence. Occasionally, cells in  the  bone 
marrow became stained with anti-mouse IgG in both normal joints and arthritic 
joints. 
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FIGURE 2.  Photomicrograph  of an arthritic joint from a mouse with passively transferred 
arthritis  72 h after injection of immunoglobulin concentrate. 
50  .-~ 
FIGURE 3.  Time course  of passively transferred arthritis  in a representative  mouse after 
injection of concentrate  from 2 ml of serum from immunized donors on 2 consecutive days 
(,D. Swelling was measured at the ankle and dorsum of  the foot using a constant tension calipers 
(Mean __. 1 SD). Anticollagen antibody levels were measured by ELISA using a 1:1,000 dilution 
of serum. 
to  Unimmunized  Recipients.  l~SI-labeled anticollagen  antibodies  and  l~lI-labeled 
normal immunoglobulin were administered intravenously to unimmunized mice. 
At various intervals these recipients were sacrificed, dissected, and tested for the 
quantity  of each  label  in  the  limbs,  ears,  and  internal  organs.  The  125I label 
concentrated  selectively  in  the  limbs  within  1/2  h  and  peaked  at  1  h  after 
administration of the antibody (Fig.  5).  By 24 h,  81% of the  125I-labeled anticol- 
lagen  antibodies  disappeared  from the  serum  compared with  only 46%  of the 
l~lI-labeled nonspecific  immunoglobulin.  If the  distribution  of anticollagen  an- 384  SERUM  TRANSFER  OF  COLLAGEN-INDUCED ARTHRITIS  IN  MICE 
FIGURE 4.  Immunofluorescence after reaction of fluorescein  conjugated rabbit anti-mouse 
C3 with a section from the hindpaw of a mouse with passively transferred arthritis.  Reaction 
with anti-mouse  IgG showed an  identical  pattern.  There were immune complexes  on the 
articular  surface  of the  cartilage  in  a  smooth  linear  pattern.  A  normal joint  showed  no 
fluorescence  with either conjugate.  Absorbtion of the anti-IgG and anti-C3  conjugates  with 
purified IgG or preformed immune complexes,  respectively,  eliminated  the specific fluores- 
cence. 
| 
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FIGURE 5.  Time course of the accumulation of z25I-labeled anticollagen  antibodies  (0) and 
~3q-labeled normal immunoglobulin (O) in the hind limbs of mice receiving  approximately 
equal  quantities  of both  intravenously.  Each  data  point  represents  the  mean  __  standard 
deviation of both hind limbs from two mice. 
tibodies  and  control  immunoglobulin  was  determined  solely  by  circulation  to 
particular tissues,  then their ratio in those tissues and in serum should have been 
the same.  However, at  1 h  after administration,  the  125I label  settled  selectively 
in the limbs,  ears,  eyes, trachea,  and  intestines.  Other  internal  organs including 
the  heart,  lungs,  kidneys,  spleen,  and  liver did not attract  this  disproportionate 
amount of 125I (Table  II). 
Transfer  of Disease Does Not  Depend  on  the 14-2 Haplotype.  Arthritis  in  mice 
immunized  with  chick  type  II collagen  has been  linked  to the  major  histocom- 
patibility complex and specifically to the H-2  q haplotype (1 3).  Strains with other STUART  AND  DIXON 
TAnLE  II 
Distribution of Isotopically Labeled Anticollagen Antibodies (~esI) as 
Compared to Normal IgG (1~1I) ! H After Administration 
Ratio  Concentration  % of Total  s 
Organ  125I/lSll  index*  1~51  lSl I 
Blood  0.68  --  49.0  60.0 
Hind feet  1.35  2.0  1.1  0.6 
Fore feet  1.35  2.0  0.5  0.3 
Ears  1.31  2.0  0.2  0.1 
Eyes  1.99  2.9  0.2  0.1 
Trachea  1.34  2.0  1.7  1.0 
Spleen  0.45  0.7  0.4  0.8 
Liver  0.53  0.8  7.6  11.5 
Lungs  0.85  1.2  1.9  1.8 
Kidneys  0.57  0.8  2.7  3.8 
Heart  0.65  1.0  1.1  1.3 
Intestine  2.27  3.3  15.5  5.4 
* Concentration index =  125I to ~s~I ratio in organ divided by the 1251 to 
131I ratio in serum. A number >1  would indicate relative concentration 
of anticollagen antibody as compared to its level in serum. 
s Quantity of each isotope detected as a  percentage of the total adminis- 
tered. 
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TABLE  III 
Transfer of Arthritis  to Several Different Strains 
Recipient strain 
Antibody re-  Arthritis after 
Recipient H-  sponse to im-  passive transfer 
munization 
2 haplotype  with type II  of serum  s (ar- 
collagen*  thritic/total) 
C57BL/6  b  ++  3/4 
B10.D2  d  +++  4/4 
BALB/c  d  ++  2/4 
C3H/He  k  +  3/4 
DBA/1  q  +++  4/4 
* Relative antibody levels achieved in each recipient strain after immuni- 
zation with chick type II collagen in complete Freund's adjuvant (refer- 
ence  13,  unpublished observation).  None  of these  strains developed 
arthritis as a result of immunization except DBA/1. 
*Transfer  serum  concentrate  was  obtained  from  immunized  DBA/1 
donors. Each unimmunized recipient received the immunoglobulin con- 
centrate from 2.25 ml of serum on each of the 2 consecutive days. 
haplotypes  did  not  develop  arthritis  despite  the  high  levels  of antibodies  to 
collagen some attained. To determine whether resistance to arthritis results from 
failure of an effector mechanism,  from active suppression,  or from qualitative 
differences in  the  immune  response  of these strains,  an  attempt  was made  to 
transfer arthritis  to mice of several haplotypes.  Table  III  illustrates  that  all  of 
the strains tested were susceptible to arthritis passively transferred by antibodies 
to collagen, although there was minor variation in incidence and severity. 
Lesion  Formation  Does Not Depend on the Species in  Which  the Immunizing Serum 386  SERUM  TRANSFER  OF  COLLAGEN-INDUCED ARTHRITIS IN  MICE 
Originated,  Having  demonstrated  that  serum  concentrate  from  DBA/1  mice 
transferred  arthritis  to  other  strains,  we  decided  to  test  the  ability  of serum 
concentrate from rats with collagen-induced arthritis to transfer this disease to 
mice. Immunoglobulin concentrate prepared from sera of rats immunized with 
bovine type II collagen was administered intravenously to unimmunized DBA/ 
1 recipients. This rat immunoglobulin concentrate passively transferred arthritis 
as well as that  from mice (Table IV).  Volumes equivalent to those effective in 
the homologous system were used,  but the quantities of immunoglobulin  were 
about twofold greater because the concentration of circulating nonspecific IgG 
in the rats used for transfer was greater. Unimmunized rats had ,~ 12 mg/ml of 
IgG  as  compared  with  "~5  mg/ml  in  DBA/1  mice.  Quantitation  by  ELISA 
showed comparable titers of specific anticollagen IgG in sera from the arthritic 
rats and mice used as transfer donors. 
Transfer of  Disease to A rthritis-resistant B 10.D2 Mice Requires Less Serum Concentrate 
After Priming.  Immunization of B 10.D2 mice with type II collagen results in an 
anticollagen response that is comparable in magnitude to that of DBA/1  mice; 
however, the B10.D2  strain does not become similarly arthritic. Since we have 
now shown that arthritis can be passively transferred to the latter strain, either 
the immune response is qualitatively different from that of susceptible strains or 
the  immunization  induces a  suppressor  mechanism  that prevents arthritis.  To 
test the latter possibility, we used B10.D2 mice either not immunized but given 
transfer  serum,  or  immunized  with  type  II  collagen  and  4  wk  later  given 
arthritogenic doses of serum concentrate from immunized DBA/1 mice. Arthri- 
tis developed in the immunized B10.D2 mice with even greater severity than in 
those that were not immunized (Table V), thereby precluding the possibility of 
suppression. Therefore, we decided to lower the amount of serum concentrate 
injected to 50%  of the dose required for reliable transfer of arthritis in unim- 
munized DBA/1 or B 10.D2 recipients. This reduced dosage induced arthritis in 
100%  of the  immunized  B10.D2  recipients.  Thus,  prior immunization  of this 
"nonresponder" strain  decreased their requirement for transfer concentrate to 
induce arthritis.  However, in none of the mice tested was the disease as severe 
TAnLE  IV 
Transfer of  Arthritis to DBA/ I Mice Using Serum Concentrate  from 
Rats Immunized with Bovine Type II Collagen (BII) 
ml of Concentrate 
Donors immunized  given to recipients*  Recipients 
with:*  arthritic/total 
Day 0  Day 1 
ICF only  0.75  0.75  0/4 
ICF + BII  0.75  0.75  5/6 
ICF + BII  1.00  None  1/6 
* Donor  Wistar/Furth rats  received  100 #g of collagen emulsified in 
incomplete Freund's  adjuvant  (ICF) intradermally  in  the  footpad, a 
repeat injection of an identically prepared emulsion 7 d later and were 
bled 16 d after the initial injection. 
*  Sera from immunized donors  were pooled; the immunoglobulin was 
precipitated with ammonium sulfate and the precipitate redissolved so 
that each 3 ml of sera yielded 1 ml of concentrate. STUART  AND  DIXON  387 
TABLE  V 
Effect of Priming* on Ability of DBA/1 Sera to Transfer Arthritis to 
BIO.D2 Mice 
ml of Concentrate* 
Recipient  given to recipients  Arthritic/  total  Mean severity  ! 
Day 0  Day 1 
Unprimed  0.75  0.75  4/4  3.25 +- 1.0 
Primed  0.75  0.75  4/4  6.25 + 1.3 
Unprimed  0.75  None  0/4  0 
Primed  0.75  None  4/4  5.5 + 1.3 
* B10.D2 were primed by immunization with 25  #g of chick type II 
collagen in complete Freund's adjuvant 4 wk before administration of 
transfer concentrate. These mice were not susceptible to arthritis as a 
result of priming without serum transfer. 
* Sera from immunized donors were pooled; the  immunoglobulin was 
precipitated with ammonium sulfate, and the precipitate redissolved so 
that each 3 ml of sera yielded 1 ml of concentrate. 
a Mice were graded for arthritis severity  daily by visually  scoring each limb 
from 1-4 (maximum severity =  16). Calculations  are based on highest 
score achieved during the course of observation. 
as that in immunized DBA/1  mice. The usual consequence of arthritis in DBA/ 
1  mice  after  immunization  was  ankylosis  and  permanent  deformity.  These 
sequelae were not seen even in immunized B 10.D2 mice after passive transfer. 
Discussion 
Collagen-induced arthritis in mice can be passively transferred with an immu- 
noglobulin concentrate from immunized donors. Histopathologically, the arthri- 
tis resembled that induced by immunization with collagen. Synovial proliferation, 
subsynovial infiltration of inflammatory cells, early pannus formation, destruc- 
tion of cartilage, and marginal erosion were all characteristic of the transferred 
disease.  Previously,  collagen-induced arthritis  was  also  transferred  to  rats  by 
using serum, and anticollagen antibody proved to be responsible for the lesion 
(11). Other investigators, who depleted complement in rats by using cobra venom 
factor, found that the onset of arthritis was delayed until the complement levels 
returned toward normal (19).  These data support the concept that arthritis in 
rats and mice is caused by similar mechanisms and that humoral immunity plays 
an important role. 
One characteristic of collagen-induced arthritis is synovial proliferation, which 
can be detected before changes in the articular cartilage are evident. Since type 
II collagen is not known to be present in synovium, the reason for this involve- 
ment is uncertain. Our studies clearly demonstrated deposition of IgG and C5 
on the articular surface in the absence of detectable IgG in synovial tissue. By 
light microscopy the cartilage appeared normal, while the synovial tissue became 
inflamed.  The  IgG  apparently  localized  to  the  cartilage  by  direct  binding, 
forming immune complexes in  situ  that activated complement.  Synovitis may 
have resulted  from  (a)  complement-mediated chemotaxis of synovial cells,  (b) 
activation of synovial cells via their Fc receptors (20), or (c) activation of synovial 
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the hypothesis that deposition of anticollagen antibodies on the cartilage surface 
can initiate arthritis and may be responsible for synoviai proliferative changes in 
the absence of other inciting events, and that this can occur without cartilage 
damage evident by light microscopy. 
The  passively  transferred arthritis  was  transient.  This  was  expected,  since 
anticollagen activity rapidly disappeared from the serum after transfer. Isotopi- 
cally labeled anticollagen antibodies selectively localized to the joints within 30 
min of intravenous administration but by 24  h  had virtually disappeared both 
from  sera  and  limbs.  Thus,  antibodies  readily bound  to  intact  cartilage  but 
apparently were rapidly catabolized after binding. The isotopically labeled im- 
munogiobulin had been exposed to conditions of low pH and oxidation during 
labeling  and  may have  partially  denatured,  accounting in  part  for  its  rapid 
disappearance. However, after administration of unlabeled concentrate, anticol- 
lagen activity in serum also declined rapidly, confirming that antibody localized 
to the cartilage quickly after intravenous administration of the concentrate. 
Only a  small percentage of the  l~SI-labeled  anticollagen antibodies adminis- 
tered was  detected in  each limb.  But  the amount of cartilage present in  the 
samples was also small compared with that in the entire body. The limbs were 
removed just proximal to the ankles and wrists so that the knees, hips, elbows, 
and shoulders, which contain large amounts of cartilage, all remained with the 
carcass. Anti-type II collagen antibodies also bound to cartilage in locations other 
than joints.  Proportionately more activity was actually seen in the trachea than 
in joints.  Some activity was even detected in the eye, where type II collagen is 
present as a constituent of the vitreous (22). 
When  collagen-induced arthritis  in  rats  was  first described,  only lesions of 
joints were reported (1). As established later, some rats also developed lesions of 
the external ear caused by chondritis of the underlying cartilage plate (23).  In 
addition,  some  rats  had  decreased  hearing  and  vestibular  dysfunction  from 
inflammation in  the inner ear (24,  25).  The precise pathophysiology of these 
lesions  has  yet to  be  identified and  they are  unknown in  mice.  The  present 
studies suggest that anticollagen antibodies are specifically concentrated in di- 
verse places within the body wherever type II collagen is located. The potential 
for destructive lesions of other cartilaginous tissues in mice needs further study 
to  determine whether lesions  may exist  elsewhere or,  if not,  why no  lesions 
develop in spite of apparent antibody binding. 
A relatively large concentration of 125I  was also noted in the intestines. This 
was  probably  caused by preferential  catabolism  of anticollagen antibody and 
excretion of the label into the feces. Such preferential destruction could have 
resulted from greater denaturation of anticollagen antibodies or from their rapid 
catabolism after specific binding, activation of complement, and involvement in 
an inflammatory process. For two reasons, preferential destruction probably was 
not caused by greater denaturation of the specific antibodies. First, both specific 
antibody and normal immunoglobulin were labeled simultaneously in the same 
buffers so that both were exposed to identical conditions of pH and oxidation. 
Second,  if  the  anticollagen  antibodies  were  nonspecifically removed  by  the 
reticuloendothelial system, then relatively more  125I  than ~31I should have been 
found in the liver and spleen. Since this was not the case, the faster catabolism STUART  AND  DIXON  389 
of anticollagen seems more likely related to its specific binding. 
Susceptibility to arthritis  induced by immunizing mice with collagen, as op- 
posed to transferring the disease with antibody to collagen, is linked to the H-2 
major histocompatibility complex (13).  All susceptible  strains  developed high 
levels of specific immunity after immunization with type II collagen. However, 
resistant  strains  varied  in  their  anticollagen  response  after  immunization;  in 
some, antibody titers against collagen were as high as those of arthritis-susceptible 
strains.  For example, the response of resistant B10.D2  mice was quantitatively 
equal to that of susceptible DBA/1  mice. The failure of this strain to become 
arthritic cannot result from either intrinsic host factors that reduce susceptibility 
or the induction of nonspeciflc suppressor mechanisms by immunization, since 
both naive and collagen-immunized B10.D2 mice became arthritic after passive 
transfer. Evidently, the response to immunization is qualitatively different, and 
B10.D2  mice may lack a  critical antibody.  This  means there is a  diversity of 
anticollagen antibodies, some of which are arthritogenic, whereas others are not. 
The situation must be more complex, however, than the simple presence or 
absence of a particular antibody. Immunization of B 10.D2 mice did not prevent 
transfer of arthritis, but rather heightened susceptibility. The cause could have 
been either induction of low levels of arthritogenic antibody in this strain or a 
capacity for other anticoilagen antibodies and cellular mechanisms to lower the 
threshold  of disease  production  and  to  aggravate  the  lesion,  once  initiated. 
Perhaps only a  few epitopes on type II  collagen are accessible on cartilage in 
vivo. Once cartilage is damaged, other epitopes are exposed that then participate 
in the inflammatory reaction. For example, the proliferative response of cells to 
collagen is primarily directed against determinants on the denatured molecule 
(18, 26). Such determinants may be concealed in normal, intact cartilage. 
The ability of serum concentrate from arthritic rats to transfer arthritis  to 
mice is  interesting for at  least two  reasons.  It  establishes  that  transfer is  not 
species specific and that arthritis may result from the same mechanisms in both 
species.  In  addition,  the  rats  were  immunized with  bovine  type  II  collagen 
because of its effectiveness in inducing disease in this species. However, DBA/1 
mice are relatively resistant to induction of arthritis by bovine collagen; chick 
collagen is much more effective. A possible explanation is that multiple epitopes 
are  present  on  both  chick  and  bovine  type  II  collagen.  A  response  to  the 
arthritogenic epitope(s) may be influenced by responses to other epitopes on the 
same  molecule causing  different overall  responses  by  the  DBA/1  mice  and 
Wistar/Furth rats used in these experiments. An alternative explanation would 
be that arthritis is caused by the sum of responses to several epitopes and that 
mice and  rats  respond  to  overlapping,  but  not  identical,  subsets  of epitopes. 
Comparison of the reactivity of mouse and rat antisera against chick and bovine 
collagen, respectively, for reactivity with mouse type II collagen would help to 
clarify this point. 
We have not attempted to address the role of cellular immunity to collagen in 
arthritic animals after immunization. The acute lesions, including synovitis, seem 
to be inducible by humoral immunity alone. We have shown that arthritis after 
passive transfer is caused by binding of antibody to the articular surface of  joint 
cartilage and that susceptibility to arthritis depends on particular antibodies in 390  SERUM  TRANSFER  OF  COLLAGEN-INDUCED  ARTHRITIS IN  MICE 
the  transfer  concentrate,  not  upon  the  host  milieu.  Nevertheless,  the  host's 
immune status  can affect disease severity and  the threshold of susceptibility. 
From these data we postulate that at least three stages mark the development of 
collagen-induced arthritis. First is a preclinical accumulation of antibody on the 
joint  surface,  second  is  an  acute  inflammatory reaction  occurring when  the 
antibody reaches a  critical level, and third is a  chronic inflammatory reaction 
resulting from exposure of denatured collagen and influx of cells following the 
second stage.  Although this  postulate is somewhat speculative, it is consistent 
with our data and provides testable predictions. 
Summary 
Immunization of DBA/1  mice with native chick type II collagen resulted in 
development of polyarthritis 4-5  wk later.  Sera of these mice contained high 
levels of anticollagen antibodies, and immunoglobulin concentrates of their sera 
transferred arthritis  to  unimmunized recipients.  Histopathologically,  this  pas- 
sively transferred arthritis  resembled the early disease of immunized donors. 
Immunofluorescence studies demonstrated the deposition of IgG and C3 on the 
articular  surface  but  not  in  synovial  tissue  of arthritic joints.  Transferred, 
isotopically labeled anticollagen antibodies rapidly localized to the limbs and to 
other cartilage-containing tissues. When transfer concentrate was administered 
to arthritis-resistant strains, they also developed arthritis. Indeed, immunoglob- 
ulin concentrates from rats with collagen-induced arthritis transferred arthritis 
to  naive  mice.  The  amount  of concentrate required  for  transfer  to  B10.D2 
resistant  mice  was  reduced  by  immunizing them  with  collagen  4  wk  before 
transfer. Although susceptibility to arthritis from immunization is H-2 linked, 
these studies clearly demonstrate that passive transfer of arthritis depends upon 
injection of specific antibody and not on other host factors. 
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